Why Choose Private Prescription for Mounjaro and Wegovy?
Private vs NHS Route: Mounjaro and Wegovy Access Comparison
The NHS pathway for both Mounjaro and Wegovy requires GP referral to specialist weight management services, often involving 6+ month waiting periods before initial consultation. Private prescription eliminates these bottlenecks entirely, providing direct access to both treatments through qualified prescribers who can assess your suitability within working days rather than months. This streamlined approach means identical medications - genuine Novo Nordisk Wegovy and authentic Eli Lilly Mounjaro - without the traditional healthcare system delays that prevent timely weight management intervention.
Private prescription also removes the restrictive NHS criteria that often exclude patients who could benefit from either Mounjaro or Wegovy treatment. While NHS services typically require evidence of multiple failed diet attempts and specific BMI thresholds with documented comorbidities, private assessment focuses on clinical appropriateness and patient-centred care. Both treatments remain prescription-only medicines requiring proper medical oversight, but the pathway becomes accessible rather than restrictive, allowing earlier intervention when motivation and circumstances align optimally.
Mounjaro and Wegovy Pricing: Transparent Private Prescription Costs
EverydayMeds offers competitive pricing for both Mounjaro and Wegovy private prescriptions, with Wegovy starting at £79.99 for the 0.25mg starter dose and progressing to £209.99 for the 2.4mg maintenance dose. New customers benefit from discount code FIRST40, while returning patients can apply DOSE25 at checkout to reach these final prices. Our bundle options provide convenient multi-month supply, such as the Intro Duo (0.25mg & 0.5mg Wegovy) at £169.99, ensuring treatment continuity without repeated ordering processes.
Mounjaro pricing follows a similar transparent structure, with both treatments representing significant value compared to potential private clinic consultations plus separate pharmacy dispensing fees. The cost includes prescriber assessment, clinical review, and temperature-controlled delivery from our GPhC-registered facility (#9012878). Unlike some private services that add hidden consultation fees or membership charges, our pricing covers the complete prescription service from assessment through to doorstep delivery, making private access to both Mounjaro and Wegovy financially predictable.
Clinical Evidence: Mounjaro and Wegovy Trial Data
Wegovy demonstrated substantial weight management efficacy in the STEP clinical programme, with participants achieving approximately 15% average weight loss at 68 weeks when combined with reduced-calorie diet and increased physical activity, as reported by Wilding et al. in NEJM, 2021. The SELECT cardiovascular outcomes trial further showed 20% reduction in major cardiovascular events, establishing Wegovy's broader health benefits beyond weight management alone.
Mounjaro's clinical evidence stems from the SURMOUNT trials, where tirzepatide showed significant weight management outcomes through its dual GIP and GLP-1 receptor agonist mechanism. Both treatments require proper medical supervision and work alongside lifestyle modifications rather than as standalone solutions, with individual responses varying based on adherence, baseline characteristics, and concurrent health interventions throughout the treatment period.
How Wegovy and Mounjaro Work: Mechanism Differences
Wegovy contains semaglutide, a selective GLP-1 receptor agonist that mimics natural fullness hormones produced in the intestine after meals. This mechanism reduces appetite by acting on brain appetite centres, promotes earlier satiety during eating, and may reduce food cravings by modulating reward pathways associated with high-calorie food consumption. The once-weekly injection provides sustained hormone activity, creating consistent appetite regulation throughout the treatment week. Mounjaro utilises tirzepatide, a dual GIP and GLP-1 receptor agonist that provides complementary appetite and metabolic effects through two distinct hormone pathways simultaneously.
Ordering Process: Mounjaro and Wegovy Private Prescription
Our streamlined ordering process begins with a comprehensive 3-minute clinical assessment covering medical history, current medications, weight management goals, and contraindication screening for both Mounjaro and Wegovy consideration. Qualified prescribers review submissions within standard 3 working days, or express 24-hour service for urgent requirements, determining treatment suitability and appropriate starting protocols. Once approved, medications dispatch via next-day delivery using cold-chain transport to maintain temperature integrity throughout transit. The FlexTouch pen system (Wegovy) and KwikPen delivery device (Mounjaro) arrive with comprehensive administration guides, dose escalation schedules, and ongoing support contact details. Both treatments require systematic dose increases according to licensed protocols, with our team monitoring progress and providing guidance throughout the titration process.
Storage and Practical Considerations: Mounjaro vs Wegovy
Both Mounjaro and Wegovy require refrigerated storage at 2-8°C before first use, but differ significantly in room temperature tolerance once removed from refrigeration. Wegovy maintains stability for up to 6 weeks at room temperature below 30°C, compared to Mounjaro's 21-day room temperature limit, providing greater travel flexibility for patients with mobile lifestyles. The dose escalation schedule spans 16 weeks for Wegovy (0.25mg to 2.4mg maintenance) while Mounjaro follows its own specific titration protocol, with both requiring strict adherence to prevent gastrointestinal side effects. Pre-filled pen devices eliminate measurement errors and provide consistent dosing, though patients must rotate injection sites and follow proper disposal protocols. Storage temperature monitoring during delivery ensures medication efficacy from our pharmacy to your door, maintaining the cold-chain integrity essential for these prescription-only medicines.
Why Private Prescription Suits Mounjaro and Wegovy Patients
Private prescription particularly benefits patients whose work or lifestyle schedules conflict with traditional NHS appointment structures, allowing assessment completion during convenient hours without employer notification or time off requirements. The discrete packaging and direct delivery system maintains privacy while ensuring clinical oversight through qualified prescriber involvement. Many patients find private prescription more suitable for long-term weight management planning, as treatment continuity doesn't depend on ongoing NHS specialist availability or changing local commissioning decisions.
Geographic location becomes irrelevant with private prescription access, eliminating postcode lottery issues that affect NHS specialist weight management service availability across different UK regions. Rural patients especially benefit from avoiding lengthy travel to specialist centres, while maintaining equivalent clinical standards through our remote assessment and monitoring protocols for both Mounjaro and Wegovy treatment pathways.
Start Your Mounjaro or Wegovy Journey Today
EverydayMeds provides seamless access to both Mounjaro and Wegovy through our private prescription service, with new customers using code FIRST40 and returning patients applying DOSE25 at checkout for optimal pricing. Our qualified prescribers can help determine which treatment aligns with your clinical profile and weight management objectives during the straightforward online assessment process. Visit https://everydaymeds.co.uk/collections/wegovy to begin your assessment today, knowing that both treatments arrive with comprehensive support, proper medical oversight, and the convenience that private prescription provides. The decision between Mounjaro and Wegovy becomes clearer with expert guidance, eliminating the uncertainty that often accompanies weight management treatment selection. Both options represent clinically proven approaches to sustainable weight management when combined with appropriate lifestyle modifications and ongoing medical supervision.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
